75 results
8-K
EX-99.1
KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares
23 Apr 24
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
7:34am
sold
Collaboration expenses
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Other income
Loss
PRE 14A
KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares
10 Apr 24
Preliminary proxy
5:00pm
and reimbursement for our products and product candidates, if approved; clinical and commercial activities; research and development costs; timing of regulatory … that were licensed to Bayer AG. Previously, he was with Pfizer Inc. as Senior Vice President of Pfizer Global Research and Development, and the director
8-K
EX-99.2
KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares
2 Apr 24
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
7:32am
$270.3M $220.2M Cost of Goods Sold $9.6M $6.7M $33.4M $22.9M Collaboration Expenses1 $16.9M $7.5M $56.5M $24.1M Research and Development $20.1M $14.4M
8-K
EX-99.1
s9s245fk8fx0 2t
28 Feb 24
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
7:35am
8-K
EX-99.2
ndzj6
4 Jan 24
Kiniksa Pharmaceuticals Provides Corporate Update
7:37am
CORRESP
z3ua3rl1
8 Dec 23
Correspondence with SEC
12:00am
8-K
EX-99.1
w0cd9 cflu34s
31 Oct 23
Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution
7:35am
8-K
EX-99.1
83pilal8zbudhdy
25 Jul 23
Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
7:40am
8-K
EX-99.1
jgc4q9w1266cf9
2 May 23
Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution
7:34am
8-K
EX-99.1
ic4m 53gvc
1 Nov 22
Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:06am
8-K
EX-99.1
po9ww43
3 Aug 22
Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:35am